Why is Titan Biotech falling/rising?

As of 30-Jul, Titan Biotech Ltd's stock price is currently at 433.95, reflecting a decrease of 3.2, or 0.73%. The stock has been underperforming, having fallen consecutively for the last five days, resulting in a total decline of 3.77% over that period. It is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, the delivery volume has decreased by 6.72% compared to the 5-day average, suggesting a decline in investor participation. The company has also reported negative results for the last three consecutive quarters, with a significant drop in profit before tax and a decline in net sales growth, contributing to a perception of poor long-term growth.
In the broader market context, Titan Biotech's short-term performance has been notably worse than the benchmark, with a 1-week return of -3.77% compared to the Sensex's -1.50%. This underperformance is further highlighted by the stock's year-to-date return of -40.78%, contrasting sharply with the Sensex's positive return of 4.28%. Despite having a high return on equity and a low debt-to-equity ratio, the stock's valuation remains high compared to its peers, which, combined with declining profits and negative quarterly results, has led to a negative sentiment among investors. Overall, the combination of poor financial performance and declining investor interest has resulted in the stock's recent downward movement.